Sotorasib is a pharmaceutical raw material used in the manufacturing of active pharmaceutical ingredients. It is a compound that targets the G12C mutation in the K-Ras protein, relevant for research in oncology.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Sotorasib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Sotorasib
pharmaceutical raw material
Clodronate disodium
pharmaceutical raw material
Diacetolol
pharmaceutical raw material
Alexidine
pharmaceutical raw material
(+)-Catechin hydrate
pharmaceutical raw material
6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-yl-3-pyridinyl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one
NXQKSXLFSAEQCZ-SFHVURJKSA-N
C[C@H]1CN(CCN1C2=NC(=O)N(C3=NC(=C(C=C32)F)C4=C(C=CC=C4F)O)C5=C(C=CN=C5C(C)C)C)C(=O)C=C
Sourcing Sotorasib?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.